Philips hits new 52-week low after U.S. order intake slips 1% and large Connected Care orders move to Q3
AI Market Summary
Philips shares hit a 52-week low despite an EPS and revenue beat, as investors focused on weaker order intake and underlying margin pressure once a one-off U.S. tariff refund is excluded. Comparable orders fell 1% due to delayed large Connected Care deals, while Diagnosis & Treatment margins faced inflation, tariffs, and China weakness. Guidance upgrades are largely mechanical from the refund, limiting reassurance on core trends.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT-1.16%
AI Insight · NCCOGOLD2USD/USDTAI Insight
▼ Bearish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Philips (PHG) fell to a new 52-week low even as it posted adjusted EPS of 57 cents, above the 40-cent consensus, on sales of $5.068 billion that slightly topped expectations. U.S. comparable order intake declined 1% as the timing of some large Connected Care orders shifted into the third quarter. Adjusted EBITA came in at 717 million euros and the margin rose to 16.4%, including a 4.2 percentage-point benefit from a U.S. tariff refund. The stock was down 1.80% at $24.57 at the time of publication on Tuesday, according to Benzinga Pro data.
